Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study

Cortical lesions (CLs) and atrophy are pivotal in multiple sclerosis (MS) pathology. This study determined the effect of disease modifying drugs (DMDs) on CL development and cortical atrophy progression in patients with relapsing-remitting MS (RRMS) over 48 months. Patients (n = 165) were randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Francesca, Perini, Paola, Atzori, Matteo, Favaretto, Alice, Seppi, Dario, Gallo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353660/
https://www.ncbi.nlm.nih.gov/pubmed/25802758
http://dx.doi.org/10.1155/2015/369348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353660/
https://www.ncbi.nlm.nih.gov/pubmed/25802758
http://dx.doi.org/10.1155/2015/369348

Ejemplares similares